| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 709440 | Null | 0.0108954273764103 | -0.099914329 |
| NSC 709483 | Null | 0.0108954273764103 | 0.2648714 |
| NSC 714379 | Null | 0.0108954273764103 | 0.1861008 |
| NSC 720447 | Null | 0.0108954273764103 | -0.26776376 |
| NSC 723548 | Null | 0.0108954273764103 | 0.39588112 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0108954273764103 | 0.23489611 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0108954273764103 | 0.32028307 |
| NSC 733504 | Everolimus | 0.0108954273764103 | -0.17963284 |
| NSC 740024 | 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine | 0.0108954273764103 | 0.10748127 |
| NSC 756404 | GW843682X | 0.0108954273764103 | 0.5042703 |